NCT06929663View on ClinicalTrials.gov

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

November 5, 2026

Study Completion Date

May 5, 2027

Conditions

Advanced Solid Tumors

Interventions

DRUG

AK146D1 for injection

AK146D1 for injection is an anti-Trop2/Nectin4 bispecific antibody-drug conjugate

Trial Locations (1)

Unknown

RECRUITING

Scientia Clinical Research, Sydney

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Akeso

INDUSTRY

NCT06929663 - A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors | Biotech Hunter | Biotech Hunter